LncRNA MAGI2-AS3 has also been explored in cancer and it appears that MAGI2-AS3 is able to modulate molecular pathways such as Fas/FasL to suppress breast cancer, bladder cancer, and hepatocellular carcinoma [138,139]. This evidence concerns the gene PDS5B and urinary bladder carcinoma.